About Serene Medical
Serene Medical is a Healthcare company based in San Ramon (United States) founded in 2010. Handheld device for selective modulation of target motor nerves to treat aesthetic conditions. Serene Medical has raised $3 million across 1 funding round from investors including M.H. Carnegie & Co and Blue Sky Alternative Investments. Its focus areas include Life Sciences, Dermatology, Medical Devices and Therapeutic Devices. Its competitors include ThermiGen, Primaeva Medical and EndyMed; 2 of its 3 listed competitors have raised funding.
Company details
Serene Medical is a medical device company with a proprietary technology for selectively targeting overactive motor nerves. It develops the The NeuBelle System, an FDA cleared handheld device that delivers Bi-polar Radiofrequency (RF) energy to locate a target nerve and inhibit or stimulates the action of a target nerve that controls the associated muscles. These devices are designed primarily for use in cosmetic and aesthetic procedures, for example, to treat motor nerves that control facial expression of the forehead, including frown lines. Conventionally this neuroinhibition is achieved by using Neurotoxins like Botox. Using Serene Medicals technology therefore limits the patients exposure to potentially harmful neurotoxins.
- Headquarters San Ramon, United States
- SectorsHealthcare
- Website serenemedical.com
- Social LinkedIn
- Total Equity Funding$3M (USD)
in 1 rounds
- Latest Funding Round$3M (USD), Series A
Sep 2014
- InvestorsM.H. Carnegie & Co.
& 1 more
Funding Insights of Serene Medical
Serene Medical has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Series A round of $3 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3M
- Total Rounds 1
- Last Round Series A — $3M
- First Round $3M
(Sep 2014)
- Investors Count 2
All 1 funding rounds of Serene Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2014 | $3M | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Serene Medical
Serene Medical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include M.H. Carnegie & Co and Blue Sky Alternative Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment platforms are managed by M.H. Carnegie & Co. | mhcarnegie.com | Moore Park, Australia | ||
Diversified alternative investment firm | blueskyfunds.com.au | Brisbane, Australia |
Investor details for Serene Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Serene Medical
2 dated milestones of Serene Medical across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Serene Medical is founded.
- Funding First funding round of $3.0M.
Competitors of Serene Medical
Serene Medical has 3 listed competitors in our database, 2 of them funded. They include ThermiGen, Primaeva Medical and EndyMed.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| thermi.com | 2012 | Austin, United States | $8M | 79 | Thermistor-regulated energy systems are developed for aesthetic and dermatology uses. | |
| primaevamedical.com | 2005 | Pleasanton, United States | $14.25M | Aesthetic treatment devices for dermatologists and cosmetic surgeons | ||
| endymed.com | 2007 | New York, United States | Radiofrequency-based systems for aesthetic skin treatments are developed. |
Detailed competitors of Serene Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Dermatology
3 companies that operate in the same segment as Serene Medical (Dermatology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Serene Medical
Serene Medical was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Serene Medical is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.
Serene Medical is a funded company, having raised a total of $3M across 1 funding round to date. The company's 1st funding round was a Series A of $3M, raised on Sep 2014.
Serene Medical is a medical device company with a proprietary technology for selectively targeting overactive motor nerves. It develops the The NeuBelle System, an FDA cleared handheld device that delivers Bi-polar Radiofrequency (RF) energy to locate a target nerve and inhibit or stimulates the action of a target nerve that controls the associated muscles. These devices are designed primarily for use in cosmetic and aesthetic procedures, for example, to treat motor nerves that control facial expression of the forehead, including frown lines. Conventionally this neuroinhibition is achieved by using Neurotoxins like Botox. Using Serene Medicals technology therefore limits the patients exposure to potentially harmful neurotoxins.
Serene Medical's top competitors include ThermiGen, Primaeva Medical and EndyMed.
Serene Medical has 2 investors. Key investors include M.H. Carnegie & Co, and Blue Sky Alternative Investments.